Navigating Life and Cell Transportation with ImmuONE’s Amjad Saeed
Further development of the ImmuPHAGE™ model has been the focus of Amjad’s work during his…
Navigating Life and Cell Transportation with ImmuONE’s Amjad Saeed Read More »
Nurturing Tomorrow’s Biotech Leaders: A Conversation with ImmuONE’s Student Interns
At ImmuONE, we believe in fostering the growth and development of young talents in the field of biotechnology….
Nurturing Tomorrow’s Biotech Leaders: A Conversation with ImmuONE’s Student Interns Read More »
Improving safety assessments of inhaled drugs with ImmuONE’s high content image analysis approaches
More than half of aerosol medicines under development are terminated due to safety concerns. ImmuONE’s high content imaging or cell painting assays are proven to accurately predict the safety of inhaled compounds by quantifying mechanism-linked morphological and biochemical characteristics within cells, contributing to faster, more informed decision making in the early stages of inhaled drug development.
Rapid Fire Round with Nilab Haydare: Life at ImmuONE
Q: What attracted you to ImmuONE as a company?
A: I was initially drawn to ImmuONE because of my positive experience during my final year dissertation, where I worked on cell culture skills with Dr. Victoria Hutter…
Rapid Fire Round with Nilab Haydare: Life at ImmuONE Read More »
Rapid Fire Round with Nilab Haydare: Life at ImmuONE
Q: What attracted you to ImmuONE as a company?
A: I was initially drawn to ImmuONE because of my positive experience during my final year dissertation, where I worked on cell culture skills with Dr. Victoria Hutter…
Rapid Fire Round with Nilab Haydare: Life at ImmuONE Read More »
Unpacking the body on a chip: Micro-Physical Systems
The goal in every lab is to ‘work smarter, not harder.’ This is especially true in pharmacological labs, where there is an ever-greater focus..
Unpacking the body on a chip: Micro-Physical Systems Read More »
ImmuONE announces launch of first product ImmuPHAGE™ to understand the safety of inhaled substances in vitro
ImmuONE today announced the launch of ImmuPHAGE™, an in vitro assay that can evaluate how substances interact with the macrophage white blood cells found in the deep lung’s alveoli.
Successful adaptation of TK6 cells to an animal-product-free culture medium
Foetal bovine serum (FBS) is widely used in cell culture media, but may limit the human relevance of safety assessments. A new study demonstrates the successful transition of the TK6 cell line to an FBS-free medium.
Successful adaptation of TK6 cells to an animal-product-free culture medium Read More »
Q&A: Applying ImmuLUNG™ on ‘organ-on-a-chip’ platforms
Nilab Haydare is a pre-clinical scientist at ImmuONE specialising in in-vitro toxicology research. She will be presenting the poster of her study,…
Q&A: Applying ImmuLUNG™ on ‘organ-on-a-chip’ platforms Read More »
Incorporating New Approach Methodologies
Despite the increasing power of non-animal approaches, the move towards their inclusion in pharmaceutical safety testing is slow, largely due to a lack of familiarity among regulators.
Incorporating New Approach Methodologies Read More »